Loading
Breathing in an immune-activating drug could turn the lungs into bad soil for cancer seeds, at doses far too low to cause body-wide side-effects.
Inhaled GM-CSF was tested in paediatric osteosarcoma lung metastases and inhaled interleukin-2 in renal cancer, both with local immune activation, acceptable safety and underpowered efficacy. Modern versions (an inhaled interleukin-15 superagonist, an inhaled STING agonist or an inhaled anti-CD47) could be aimed at lung-metastasis prevention rather than treatment, where the target cell burden is tiny.
Shares Are 90% of deaths from cancer caused by metastases?, STING & innate immune agonists, Metastasis is understood least and studied last, Cold tumours and the immunosuppressive microenvironment.
Shares STING & innate immune agonists, CD47, Cytokines & engineered cytokines, Cold tumours and the immunosuppressive microenvironment.
Shares Cytokines & engineered cytokines, Cold tumours and the immunosuppressive microenvironment, Renal cell carcinoma, Sarcomas (soft tissue, bone, GIST).
Shares Are 90% of deaths from cancer caused by metastases?, Metastasis is understood least and studied last.
Shares Are 90% of deaths from cancer caused by metastases?, Metastasis is understood least and studied last.
Shares Are 90% of deaths from cancer caused by metastases?, Metastasis is understood least and studied last.
Shares Are 90% of deaths from cancer caused by metastases?, Metastasis is understood least and studied last.
Shares STING & innate immune agonists, Cold tumours and the immunosuppressive microenvironment, Sarcomas (soft tissue, bone, GIST).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/